13 min listen
Purdue-Discovered Drug Strengthens Fight Against Cancer | Dr. Philip Low
FromThis Is Purdue
ratings:
Length:
37 minutes
Released:
Jan 20, 2022
Format:
Podcast episode
Description
In this episode of This Is Purdue, we’re featuring a Boilermaker whose innovations are changing and saving lives across the world.
Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.
Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)
Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, developed a recently FDA-approved drug called Cytalux, a fluorescent marker that allows cancer surgeons to quickly identify malignant cells and remove them during surgery.
Listen in as Professor Low discusses how the drug works, why the team started using this drug on ovarian cancer patients first, and what attracted him to innovation at Purdue University. (Hint: He’s been a Boilermaker since birth!)
Released:
Jan 20, 2022
Format:
Podcast episode
Titles in the series (100)
Summer Vacation: <p><span style="color: rgb(51, 51, 51);">Jonathon Day, associate professor of hospitality and tourism management, is studying how to strike a balance for making tourism sustainable for future generations. Day says that sustainable tourism is about look... by This Is Purdue